세계의 유전성 망막 질환 시장 보고서(2025년)

Inherited Retinal Disease Global Market Report 2025

US $ 4,490 ￦ 6,242,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,023,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,803,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

유전성 망막질환 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 연평균 8.5%의 성장률로 174억 2,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 CRISPR의 활용 확대, 맞춤 치료의 등장, 재생의료의 발전, 환자 옹호 활동의 확대, 환자의 삶의 질 향상에 대한 관심 등이 성장의 원동력이 될 것으로 보입니다. 예측 기간의 주요 동향으로는 광유전학 기술의 발전, 인공망막 이식 개발, 디지털 헬스 플랫폼의 확대, 질병 모델링에 인공지능의 통합, 치료 계획에 인공지능의 활용 등을 들 수 있습니다.

황반변성 유병률 증가는 유전성 망막 질환 시장의 성장을 가속할 것으로 예측됩니다. 황반변성은 황반을 손상시키는 노화 관련 안질환으로 중심시력 저하, 독서 및 얼굴 인식과 같은 활동에 어려움을 초래하는 질환입니다. 황반변성 발병률 증가는 인구 고령화, 평균 수명 연장, 흡연 및 영양 부족과 같은 생활습관 선택과 같은 요인으로 인해 위험도가 높아지고 있습니다. 유전성 망막질환 치료는 망막변성의 유전적 원인을 표적으로 삼아 질환의 진행을 늦추고, 잃어버린 시력을 회복시키며, 망막의 추가 손상을 예방하는 치료법입니다. 이를 통해 노인황반변성 및 유전성 황반변성 환자의 시각적 결과와 삶의 질을 궁극적으로 개선할 수 있습니다. 예를 들어, 2024년 2월 캐나다 안과학회는 55세 이상 캐나다인 중 노화성 황반변성(AMD)으로 인한 시력 저하를 겪는 사람이 250만 명에 달할 것이라고 보고했습니다. 황반변성 유병률 증가는 유전성 망막질환 분야 시장 성장을 가속하고 있습니다.

유전성 망막 질환 시장의 기업들은 이러한 질환과 관련된 광범위한 유전적 돌연변이에 대응하기 위해 돌연변이 진단 유전자 치료와 같은 혁신적인 치료법에 집중하고 있습니다. 돌연변이 진단 유전자 치료는 특정 돌연변이가 아닌 일반적인 유전 메커니즘과 경로를 표적으로 삼기 때문에 보다 광범위한 유전성 질환에 적용될 수 있습니다. 예를 들어, 2024년 3월 미국 바이오기업 나노스코프 테라퓨틱스(Nanoscope Therapeutics)는 진행성 망막색소변성증으로 인한 중증 영구적 시력저하 환자의 시력 개선 효과를 입증한 주요 프로그램인 MCO-010의 임상시험에서 좋은 결과를 발표했습니다. MCO-010은 주요 평가항목 및 주요 부수적 평가항목을 통계적으로 유의미하게 달성했으며, 심각한 부작용은 나타나지 않았습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 유전성 망막 질환 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 유전성 망막 질환 시장 : 성장률 분석
• 세계의 유전성 망막 질환 시장 실적 : 규모와 성장, 2019-2024
• 세계의 유전성 망막 질환 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 유전성 망막 질환 TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 유전성 망막 질환 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 진단
• 치료
• 세계의 유전성 망막 질환 시장 : 질환 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 망막 색소 변성증
• 맥락막 디스트로피
• 슈타르가르트병
• 원추체 디스트로피
• 레베르 선천성 흑암시(LCA)
• 기타 병
• 세계의 유전성 망막 질환 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 소매 판매량
• 직접 입찰
• 세계의 유전성 망막 질환 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 전문 클리닉
• 외래수술센터(ASC)
• 재택 헬스케어
• 기타 최종사용자
• 세계의 유전성 망막 질환 시장, 진단별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 유전자 검사(유전자 스크리닝)
• 망막 영상 검사(안저 사진, 광간섭 단층촬영(OCT))
• 전기생리학적 검사(망막전도 검사)
• 시야 검사
• 안저 자기 형광 이미징
• 세계의 유전성 망막 질환 시장, 치료법별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 유전자 치료
• 줄기세포 요법
• 망막 보철물(인공 망막)
• 약리학적 치료(유전자 편집, 망막 치료제)
• 광수용체 구제 요법

제7장 지역별/국가별 분석

• 세계의 유전성 망막 질환 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 유전성 망막 질환 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 유전성 망막 질환 시장 : 경쟁 구도
• 유전성 망막 질환 시장 : 기업 개요
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Vertex Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Ionis Pharmaceuticals Inc.
• Invitae Corporation
• Spark Therapeutics
• Aldeyra Therapeutics
• Regenxbio Inc.
• IVERIC bio
• MeiraGTx Limited
• Ocugen Inc.
• Coave Therapeutics
• Bionic Vision Technologies
• GenSight Biologics SA
• LKC Technologies Inc.
• Sparing Vision
• ProQR Therapeutics NV
• Endogena Therapeutics

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 유전성 망막 질환 시장(2029년) : 새로운 기회를 제공하는 국가
• 유전성 망막 질환 시장(2029년) : 새로운 기회를 제공하는 부문
• 유전성 망막 질환 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Inherited retinal diseases are a group of rare genetic disorders caused by mutations in specific genes, primarily affecting the retina, the light-sensitive tissue at the back of the eye. These diseases are often challenging to treat due to their genetic complexity, but advancements in gene therapy and other innovative technologies offer promising treatment options.

The main approaches for treating inherited retinal diseases include diagnosis and therapy. Diagnosis utilizes advanced technologies such as genetic testing, optical coherence tomography, and fundus imaging to identify these diseases and determine their genetic causes. These treatments address various conditions such as retinitis pigmentosa, choroideremia, Stargardt disease, cone-rod dystrophy, Leber congenital amaurosis, and others. They are distributed through channels such as retail sales and direct tenders, and are used by various end users including hospitals, specialty clinics, ambulatory surgical centers, home healthcare settings, and others.

The inherited retinal disease market research report is one of a series of new reports from The Business Research Company that provides inherited retinal disease market statistics, including inherited retinal disease industry global market size, regional shares, competitors with a inherited retinal disease market share, detailed inherited retinal disease market segments, market trends and opportunities, and any further data you may need to thrive in the inherited retinal disease industry. This inherited retinal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inherited retinal disease market size has grown strongly in recent years. It will grow from $11.56 billion in 2024 to $12.58 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to the adoption of gene therapy, regulatory incentives, an increase in patient registries, the rise in clinical trials, and the growing focus on patient-centric solutions.

The inherited retinal disease market size is expected to see strong growth in the next few years. It will grow to $17.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. In the forecast period, growth is expected to be driven by the increased use of CRISPR, the emergence of personalized treatments, advancements in regenerative medicine, the growth of patient advocacy, and a focus on improving patients' quality of life. Key trends in the forecast period include advancements in optogenetics technology, the development of artificial retina implants, the expansion of digital health platforms, the integration of artificial intelligence in disease modeling, and the use of artificial intelligence in treatment planning.

The increasing prevalence of macular degeneration is expected to drive the growth of the inherited retinal disease market. Macular degeneration, an age-related eye condition that damages the macula, results in central vision loss and challenges with activities such as reading or recognizing faces. The rising incidence of macular degeneration is driven by factors such as aging populations, longer life expectancy, and lifestyle choices such as smoking and poor nutrition, which elevate the risk. Inherited retinal disease treatments target the genetic causes of retinal degeneration, offering therapies that can slow disease progression, restore lost vision, or prevent further damage to the retina. This ultimately improves visual outcomes and quality of life for those affected by age-related or inherited forms of macular degeneration. For example, in February 2024, the Canadian Ophthalmological Society reported that 2.5 million Canadians over the age of 55 suffer from vision loss due to age-related macular degeneration (AMD). The increasing prevalence of macular degeneration is thus fueling market growth in the inherited retinal disease sector.

Companies in the inherited retinal disease market are focusing on innovative treatments, such as mutation-agnostic gene therapy, to address a broader range of genetic variations associated with these conditions. Mutation-agnostic gene therapy targets general genetic mechanisms or pathways rather than specific mutations, making it applicable to a wider variety of genetic disorders. For example, in March 2024, Nanoscope Therapeutics Inc., a U.S.-based biotechnology company, announced positive results from a clinical trial of its lead program, MCO-010, which demonstrated vision improvements for patients with severe, permanent vision loss from advanced retinitis pigmentosa. MCO-010 achieved both primary and key secondary endpoints with statistical significance and no serious adverse events.

In October 2024, Ocuphire Pharma, Inc., a U.S.-based biopharmaceutical company, acquired Opus Genetics Inc. for an undisclosed amount. This acquisition aimed to strengthen Ocuphire Pharma's gene therapy portfolio and expedite the development of treatments for inherited retinal diseases (IRDs) by integrating Opus Genetics Inc.'s innovative gene therapies for rare retinal conditions. Opus Genetics Inc. is a clinical-stage company focused on advancing gene therapies for inherited retinal diseases.

Major players in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

North America was the largest region in the inherited retinal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inherited retinal disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the inherited retinal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inherited retinal disease market includes revenues earned by entities by providing services such as ophthalmic tests, optic nerve imaging, and electrophysiological tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inherited Retinal Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inherited retinal disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inherited retinal disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inherited retinal disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Diagnosis; Therapy
• 2) By Disease Type: Retinitis Pigmentosa; Choroideremia; Stargardt Disease; Cone-rode Dystrophy; Leber Congenital Amaurosis; Other Diseases
• 3) By Distribution Channel: Retail Sales; Direct Tender
• 4) By End Users: Hospitals; Speciality Clinics; Ambulatory Surgical Centres; Home Healthcare; Other End Users

Subsegments;

• 1) By Diagnosis: Genetic Testing (Genetic Screening); Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT)); Electrophysiological Testing (Electroretinography); Visual Field Testing; Fundus Autofluorescence Imaging
• 2) By Therapy: Gene Therapy; Stem Cell Therapy; Retinal Prosthesis (Artificial Retina); Pharmacological Therapy (Gene Editing, Retinal Drugs); Photoreceptor Rescue Therapy
• Companies Mentioned: Johnson & Johnson; Novartis AG; Astellas Pharma Inc.; Biogen Inc.; Vertex Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inherited Retinal Disease Market Characteristics

3. Inherited Retinal Disease Market Trends And Strategies

4. Inherited Retinal Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Inherited Retinal Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Inherited Retinal Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Inherited Retinal Disease Market Growth Rate Analysis
• 5.4. Global Inherited Retinal Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Inherited Retinal Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Inherited Retinal Disease Total Addressable Market (TAM)

6. Inherited Retinal Disease Market Segmentation

• 6.1. Global Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Therapy
• 6.2. Global Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinitis Pigmentosa
• Choroideremia
• Stargardt Disease
• Cone-rode Dystrophy
• Leber Congenital Amaurosis
• Other Diseases
• 6.3. Global Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Sales
• Direct Tender
• 6.4. Global Inherited Retinal Disease Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Speciality Clinics
• Ambulatory Surgical Centres
• Home Healthcare
• Other End Users
• 6.5. Global Inherited Retinal Disease Market, Sub-Segmentation Of Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing (Genetic Screening)
• Retinal Imaging (Fundus Photography, Optical Coherence Tomography (OCT))
• Electrophysiological Testing (Electroretinography)
• Visual Field Testing
• Fundus Autofluorescence Imaging
• 6.6. Global Inherited Retinal Disease Market, Sub-Segmentation Of Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Stem Cell Therapy
• Retinal Prosthesis (Artificial Retina)
• Pharmacological Therapy (Gene Editing, Retinal Drugs)
• Photoreceptor Rescue Therapy

7. Inherited Retinal Disease Market Regional And Country Analysis

• 7.1. Global Inherited Retinal Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Inherited Retinal Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inherited Retinal Disease Market

• 8.1. Asia-Pacific Inherited Retinal Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inherited Retinal Disease Market

• 9.1. China Inherited Retinal Disease Market Overview
• 9.2. China Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inherited Retinal Disease Market

• 10.1. India Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inherited Retinal Disease Market

• 11.1. Japan Inherited Retinal Disease Market Overview
• 11.2. Japan Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inherited Retinal Disease Market

• 12.1. Australia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inherited Retinal Disease Market

• 13.1. Indonesia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inherited Retinal Disease Market

• 14.1. South Korea Inherited Retinal Disease Market Overview
• 14.2. South Korea Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inherited Retinal Disease Market

• 15.1. Western Europe Inherited Retinal Disease Market Overview
• 15.2. Western Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inherited Retinal Disease Market

• 16.1. UK Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inherited Retinal Disease Market

• 17.1. Germany Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inherited Retinal Disease Market

• 18.1. France Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inherited Retinal Disease Market

• 19.1. Italy Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inherited Retinal Disease Market

• 20.1. Spain Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inherited Retinal Disease Market

• 21.1. Eastern Europe Inherited Retinal Disease Market Overview
• 21.2. Eastern Europe Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inherited Retinal Disease Market

• 22.1. Russia Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inherited Retinal Disease Market

• 23.1. North America Inherited Retinal Disease Market Overview
• 23.2. North America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inherited Retinal Disease Market

• 24.1. USA Inherited Retinal Disease Market Overview
• 24.2. USA Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inherited Retinal Disease Market

• 25.1. Canada Inherited Retinal Disease Market Overview
• 25.2. Canada Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inherited Retinal Disease Market

• 26.1. South America Inherited Retinal Disease Market Overview
• 26.2. South America Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inherited Retinal Disease Market

• 27.1. Brazil Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inherited Retinal Disease Market

• 28.1. Middle East Inherited Retinal Disease Market Overview
• 28.2. Middle East Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inherited Retinal Disease Market

• 29.1. Africa Inherited Retinal Disease Market Overview
• 29.2. Africa Inherited Retinal Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Inherited Retinal Disease Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Inherited Retinal Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inherited Retinal Disease Market Competitive Landscape And Company Profiles

• 30.1. Inherited Retinal Disease Market Competitive Landscape
• 30.2. Inherited Retinal Disease Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Vertex Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Inherited Retinal Disease Market Other Major And Innovative Companies

• 31.1. Ionis Pharmaceuticals Inc.
• 31.2. Invitae Corporation
• 31.3. Spark Therapeutics
• 31.4. Aldeyra Therapeutics
• 31.5. Regenxbio Inc.
• 31.6. IVERIC bio
• 31.7. MeiraGTx Limited
• 31.8. Ocugen Inc.
• 31.9. Coave Therapeutics
• 31.10. Bionic Vision Technologies
• 31.11. GenSight Biologics SA
• 31.12. LKC Technologies Inc.
• 31.13. Sparing Vision
• 31.14. ProQR Therapeutics NV
• 31.15. Endogena Therapeutics

32. Global Inherited Retinal Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inherited Retinal Disease Market

34. Recent Developments In The Inherited Retinal Disease Market

35. Inherited Retinal Disease Market High Potential Countries, Segments and Strategies

• 35.1 Inherited Retinal Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Inherited Retinal Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Inherited Retinal Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료